サンプル依頼リスト カート
  • English
  • Korean
表紙：インスリンパッチポンプの世界市場：2023年～2030年
市場調査レポート
商品コード
1380394

インスリンパッチポンプの世界市場：2023年～2030年

Global Insulin Patch Pumps Market 2023-2030

出版日
ページ情報
英文 95 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
インスリンパッチポンプの世界市場：2023年～2030年
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 95 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のインスリンパッチポンプ市場は、予測期間中にCAGR 9.8％で成長すると予測されています。市場の成長は、糖尿病有病率の上昇、ヘルスケア支出の増加などの要因によるものです。国際糖尿病連合によると、2021年には5億3,700万人の成人（20～79歳）が糖尿病を患っており、これは世界の10人に1人に相当します。この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。100万人の成人が耐糖能異常（IGT）であり、2型糖尿病のリスクが高いです。成人の糖尿病患者の4人に3人以上が低・中所得国に住んでいます。糖尿病による医療費は少なくとも9,660億米ドルに上り、過去15年間で316％増加しました。

さらに、食品医薬品局（FDA）の承認頻度の上昇と高度なパッチポンプに関する認知度の向上が、市場の成長を加速させています。2023年5月、米国食品医薬品局は、6歳以上の1型糖尿病患者を対象としたベータ・バイオニクスのiLet ACEポンプとiLet投与決定ソフトウェアを承認しました。これら2つの機器は、互換性のあるFDA認可の統合型持続血糖モニター（iCGM）とともに、iLet Bionic Pancreasと呼ばれる新しいシステムを開発しました。この新しい自動インスリン投与（AID）システムは、アルゴリズムを用いてインスリン投与を決定し、命令します。

セグメント別の展望

使い捨てサブセグメントがインスリンパッチポンプの世界市場で圧倒的なシェアを占めると予想される

使い捨てインスリンパッチポンプは、QOLの向上、糖尿病関連の苦痛の軽減、患者満足度の向上、環境問題への関心の高まりなどの理由で採用が拡大しています。そのため、市場プレイヤーは、世界中で高まる需要に対応するため、パートナーシップやコラボレーションを結んでいます。例えば、2023年5月、Medtronic plcは、EOFlow Co.Ltd.を買収することで合意しました。EOPatch（R）デバイスはチューブレスで装着可能な完全使い捨てのインスリン送達デバイスです。EOFlow社がメドトロニックの食事検出技術（TM）アルゴリズムと次世代持続グルコースモニター（CGM）と共に加わることで、糖尿病患者の治療過程やインスリン投与方法の好みを問わず、より多くの糖尿病患者のニーズに対応できるようになることが期待されます。

地域別展望

世界のインスリンパッチポンプ市場は、北米（米国、カナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋地域（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）の地域別にさらに細分化されています。なかでも北米地域市場は、1型糖尿病患者への普及が進み、ヘルスケア支出も増加していることから、予測期間中に大幅な成長が見込まれます。

インスリンパッチポンプの世界市場はアジア太平洋地域が予測期間中に最も速いCAGRで成長する見込み

全地域の中でアジア太平洋地域が予測期間中に最も速いCAGRで成長すると予想されるのは、同地域における糖尿病人口の急速な増加や先進的な糖尿病管理ソリューションに関する意識の高まりなどの要因によるものです。国際糖尿病連合によると、世界最大の糖尿病患者数を占めるのはインドと中国です。この地域の大半の国は発展途上国であり、肥満症例の増加と社会経済的変化の拡大がi型糖尿病とII型糖尿病の発生に拍車をかけています。東南アジアでは、成人の糖尿病患者数は2045年までに1億5,200万人に達し、68％増加すると予測されています。西太平洋地域では、2045年までに成人の糖尿病患者数は2億6,000万人に増加すると予測され、27％の増加です。

また、インスリンパッチポンプ分野での製品上市の増加や技術的進歩が地域の成長を助けると予想されます。2023年10月、Shanghai Yiyu Technology Co., Ltd.は最新世代のA8超薄型インスリンパッチポンプNano pumpを世界的に公開しました。A8超薄型インスリンパッチポンプは、世界最小、最軽量、最薄のカテーテルレスパッチポンプです。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • F. Hoffmann-La Roche Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Medtronic plc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Terumo Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Tandem Diabetes Care Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • インスリンパッチポンプの世界市場：タイプ別
    • 使い捨て
    • 再利用可能
  • インスリンパッチポンプの世界市場：流通チャネル別
    • 病院
    • 個人クリニック
    • 小売薬局
    • その他（オンライン薬局）

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Becton, Dickinson and Co.
  • CeQur SA
  • Debiotech SA
  • Diabetes.co.uk
  • Edwards Health Care Services, Inc.
  • EOFlow Co., Ltd.
  • Insulet Corp.
  • Medtrum Technologies Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Roche Diabetes Care, Inc
  • SOOIL Developments Co., Ltd.
  • ViCentra B.V.
  • Ypsomed AG
図表

LIST OF TABLES

  • 1. GLOBAL INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL DISPOSABLE INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL REUSABLE INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 5. GLOBAL INSULIN PATCH PUMPS BY HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL INSULIN PATCH PUMPS BY PRIVATE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INSULIN PATCH PUMPS BY RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)

GLOBAL INSULIN PATCH PUMPS BY OTHER DISTRIBUTION CHANNELS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)

  • 8. GLOBAL INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 12. EUROPEAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. EUROPEAN INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD INSULIN PATCH PUMPS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INSULIN PATCH PUMPS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL DISPOSABLE INSULIN PATCH PUMPS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL REUSABLE INSULIN PATCH PUMPS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL INSULIN PATCH PUMPS MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 5. GLOBAL INSULIN PATCH PUMPS BY HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL INSULIN PATCH PUMPS BY PRIVATE CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL INSULIN PATCH PUMPS BY RETAIL PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL INSULIN PATCH PUMPS BY OTHER DISTRIBUTION CHANNELS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL INSULIN PATCH PUMPS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD INSULIN PATCH PUMPS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027862

Title: Global Insulin Patch Pumps Market Size, Share & Trends Analysis Report by type (Disposable and Reusable), and by Distribution Channel (Hospitals, Private Clinics, Retail Pharmacies and Others),Forecast Period (2023-2030).

The global insulin patch pump market is anticipated to grow at a CAGR of 9.8% during the forecast period. The growth of the market is attributed to factors such as the rising prevalence of diabetes, and increasing healthcare expenditure. According to the International Diabetes Federation, in 2021, 537 million adults (20-79 years) are living with diabetes - 1 in 10 around the globe. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. People million adults have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes. Over 3 in 4 adults with diabetes live in low- and middle-income countries. Diabetes caused at least $966 billion dollars in health expenditure, a 316% increase over the last 15 years.

Moreover, the rising frequency of Food and Drug Administration (FDA) approvals and increasing awareness regarding advanced patch pumps are accelerating market growth. In May 2023, the US Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes. These two devices, along with a compatible FDA-cleared integrated continuous glucose monitor (iCGM), developed a new system called the iLet Bionic Pancreas. This new automated insulin dosing (AID) system uses an algorithm to determine and command insulin delivery.

Segmental Outlook

The global insulin patch pumps market is segmented based on the type, and distribution channel. Based on the type, the market is sub-segmented into disposable and reusable. Further, based on distribution channels, the market is sub-segmented into hospitals, private clinics, retail pharmacies, and others. Among the distribution channels, retail pharmacies is anticipated to grow over the forecast period owing to the assisting navigate symptoms, retail pharmacies handle a variety of prescriptions and give guidance to avoid side effects and drug interactions.

Disposable Sub-Segment is Anticipated to Hold a Prominent Share in the Global Insulin Patch Pumps Market

Among the types, disposable insulin patch pumps sub-segment is anticipated to hold a considerable share of the market, owing to the growing adoption of disposable insulin patch pumps to improve quality of life, reduce diabetes-related distress, increase patient satisfaction, and increasing environment concern. Thus, the market players are entering into partnerships and collaborations for catering to the growing demand across the globe. For instance, in May 2023, Medtronic plc, entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device, a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

Regional Outlook

The global insulin patch pumps market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the North America regional market is expected to grow considerably over the forecast period, rising adoption among type 1 diabetes patients, and increasing healthcare expenditure.

Asia Pacific is Expected to Grow at the fastest CAGR over the Forecast Period in the Global Insulin Patch Pumps Market

Among all regions, Asia Pacific is expected to grow at the fastest CAGR over the forecast period due to factors such as the rapidly growing diabetic population and increasing awareness regarding advanced diabetes management solutions in the region. According to the International Diabetes Federation, India, and China account for the largest number of diabetes patients in the world. Most of the countries in this region are developing countries and the increase in obesity cases and growing socio-economic changes have fueled the occurrence of type I and type II diabetes. In Southeast Asia, the number of adults with diabetes is predicted to rise to 152 million by 2045, an increase of 68%. In the Western Pacific, the number of adults with diabetes is predicted to rise to 260 million by 2045, an increase of 27%.

In addition, increasing product launches and technological advancements in the field of insulin patch pumps are expected to aid regional growth. In October 2023, Shanghai Yiyu Technology Co., Ltd. revealed the latest generation A8 ultra-thin insulin patch pump Nano pump globally. The A8 ultra-thin insulin patch pump is the world's smallest, lightest, and thinnest catheterless patch pump.

Market Players Outlook

The major companies serving the global insulin patch pump market include: F. Hoffmann-La Roche Ltd, Medtronic plc., Terumo Corp., Tandem Diabetes Care Inc., Insulet Corp., SOOIL Developments Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, Medtronic plc agreed to acquisition EOFlow Co., Ltd., a company based in South Korea that makes a tubeless, disposable insulin pump on a patch. The company made a public tender offer to acquire all EOFlow's outstanding public shares for W971 billion ($738 million).

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global insulin patch pumps market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. F. Hoffmann-La Roche Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Medtronic plc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Terumo Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Tandem Diabetes Care Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Insulin Patch Pumps Market by Type
    • 4.1.1. Disposable
    • 4.1.2. Reusable
  • 4.2. Global Insulin Patch Pumps Market by Distribution Channel
    • 4.2.1. Hospitals
    • 4.2.2. Private Clinics
    • 4.2.3. Retail Pharmacies
    • 4.2.4. Others (Online Pharmacies)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Ascensia Diabetes Care Holdings AG
  • 6.3. Becton, Dickinson and Co.
  • 6.4. CeQur SA
  • 6.5. Debiotech SA
  • 6.6. Diabetes.co.uk
  • 6.7. Edwards Health Care Services, Inc.
  • 6.8. EOFlow Co., Ltd.
  • 6.9. Insulet Corp.
  • 6.10. Medtrum Technologies Inc.
  • 6.11. Micro-Tech (Nanjing) Co., Ltd.
  • 6.12. Roche Diabetes Care, Inc
  • 6.13. SOOIL Developments Co., Ltd.
  • 6.14. ViCentra B.V.
  • 6.15. Ypsomed AG